HR Execs on the Move

Reva Medical

www.revamedical.com

 
Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Jessica Earley
Senior Director of Research and Development and Program Management Profile

Similar Companies

Imaging3

Imaging3 is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Analytical Industries

Analytical Industries is a Pomona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Katahdin Industries

Katahdin Industries provides high-tolerance coating applications and specialized metal-finishing technology and services to the medical device and industrial markets through platform-focused subsidiaries including DCHN, Precision Coating, Medi-Solve Coatings and Sanford Process. Headquartered in Dedham, Mass., with operations in Woonsocket, R.I., Katahdin has earned an industry reputation as an innovative, high-quality supplier. Katahdin's technical and product development expertise, strong facilities and problem-solving culture have resulted in a track record of successful service performance for its customers. Each subsidiary is an expert provider of the services it offers. But mastery of the technology is only part of our competitive differentiation. Developing unique capabilities to handle specific applications, whether coating medical wire or finishing orthopedic equipment, allows us to provide these and other related services at a superior quality level and lower cost than other service providers. Katahdin's coating operations are conducted through Precision Coating Company, Inc., one of the largest plastics coating applicators in the world, specializing in PTFE and Teflon® coating applications in the medical device market. A separate co-located company, Precision Fabric, is a worldwide distributor and converter of PTFE-coated fabrics, tapes and belts. Specialized metal finishing services are conducted through DCHN, LLC, an industry leader in technical aluminum and titanium anodizing, electro-polish and passivation, and other related services. Sanford Process Corporation provides hard-coat anodizing solutions, as well as licenses the company's intellectual property, to a range of well-known OEMs and their prime subcontractors worldwide, with an increasing presence in Korea and China. Katahdin seeks to acquire expert service providers and formulators with a strong history of innovation, current facilities, dedicated customer service, and high-quality management. The company's acquisition strategy is flexible, offering the potential for owners to retain a stake in the business. By leveraging Katahdin's capabilities, acquired companies are able to increase growth and profitability by focusing on their customers and technology needs while expanding sales and marketing reach.

Tobii Dynavox

Tobii Dynavox, a wholly owned subsidiary of Tobii AB (publ), is the leading global provider of eye tracking enabled and touch-based augmented and alternative communication (AAC) devices as well as symbol-based products for individuals with special needs.

RenalGuard Solutions

Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical technology company specializing in innovative technologies for the cardiac and vascular markets. Our newest product, RenalGuard®, has been developed to help prevent the onset of contrast-induced nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. It is already approved for sale in the EU for general fluid balancing. Two investigator-sponsored European studies have demonstrated RenalGuard`s effectiveness at preventing CIN. RenalGuard is being studied in a pivotal trial in the U.S., as required for approval by the FDA. The RenalGuard System™ consists of a closed loop, software-controlled console and single-use sets that physicians and nurses use for automated matched fluid replacement to minimize over- or under-hydration of patients during medical procedures where creating and maintaining high urine outputs is beneficial.